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Background: Atrial fibrillation is one of the most common complications of cardiac surgery. Recently, more “off pump” surgery has been performed 
with shorter ICU and hospital stays. As a result, traditional prevention strategies are more difficult. Thus, it is important to find new therapeutic 
strategies to decrease the incidence of this common postoperative complication.
Methods: We prospectively randomized 120 patients undergoing coronary artery bypass surgery to one of four different treatment strategies to 
decrease the incidence of postoperative atrial fibrillation. All medications were given orally and begun at the time of surgery. The four strategies were: 
[1] beta blockade using oral metoprolol (25 mg bid - 50 mg tid), [2] oral amiodarone (400 mg tid), [3] atrial pacing at 100 beats per minute, and 
[4] atrial pacing + oral amiodarone. All patients were followed during their hospitalization for the development of atrial fibrillation lasting more than 
5 minutes.
Results: We enrolled 120 patients (78 men) with a mean age of 61.0 + 11.5 years. Of these, 77 (64%) had off-pump surgery. The incidence of 
postoperative atrial fibrillation was 20.8% in the metoprolol group, 10.8% in the amiodarone group, 8.8% in the atrial pacing group and 0% in the 
patients that received atrial pacing and amiodarone (p<0.05 compared with metoprolol). In addition, the length of hospital stay was 7.1 + 4.1 
days with metoprolol, 6.0 + 2.2 days with amiodarone, 7.5 + 5.8 days with atrial pacing and 5.7 + 2.3 days in the combination therapy arm. The 
combination therapy arm also had the least number of adverse events.
Conclusion: The use of oral amiodarone combined with atrial pacing, begun shortly after coronary bypass surgery, results in a reduction in the 
incidence of postoperative atrial fibrillation and a trend toward a decreased length of hospital stay compared to metoprolol therapy.
